Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CULLETTA, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.624
NA - Nord America 1.617
AS - Asia 1.240
SA - Sud America 222
AF - Africa 34
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.561
IT - Italia 641
RU - Federazione Russa 441
SG - Singapore 386
CN - Cina 273
BR - Brasile 162
VN - Vietnam 123
HK - Hong Kong 110
PL - Polonia 89
FR - Francia 88
BD - Bangladesh 75
DE - Germania 73
GB - Regno Unito 62
JP - Giappone 59
FI - Finlandia 51
IN - India 50
AT - Austria 27
NL - Olanda 27
TR - Turchia 26
KR - Corea 25
AR - Argentina 24
ES - Italia 24
CA - Canada 21
BE - Belgio 20
MX - Messico 20
IL - Israele 18
CH - Svizzera 17
IE - Irlanda 17
IQ - Iraq 16
IR - Iran 14
RO - Romania 14
AU - Australia 12
PK - Pakistan 12
SA - Arabia Saudita 12
UA - Ucraina 12
CO - Colombia 7
EC - Ecuador 7
PY - Paraguay 7
VE - Venezuela 7
ZA - Sudafrica 7
ID - Indonesia 6
JM - Giamaica 6
SE - Svezia 6
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
PT - Portogallo 5
CI - Costa d'Avorio 4
CL - Cile 4
EG - Egitto 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
PH - Filippine 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SL - Sierra Leone 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.756
Salva come PNG Salva come JPEG
Città #
Singapore 264
Palermo 231
San Jose 214
Ashburn 212
Chandler 100
Hong Kong 100
Moscow 73
Zgierz 70
New York 57
Ann Arbor 49
Fairfield 49
Ho Chi Minh City 49
Los Angeles 49
Rome 44
Council Bluffs 43
Helsinki 43
Beijing 41
Tokyo 35
Hefei 32
Lauterbourg 31
The Dalles 28
Wilmington 27
Hanoi 26
Dallas 25
Seattle 24
Milan 23
Partanna 22
Corciano 21
Woodbridge 21
Santa Clara 20
Buffalo 19
Boardman 18
Medford 18
Perugia 18
Dublin 17
Houston 17
São Paulo 16
Frankfurt am Main 15
London 15
Cefalù 14
Tel Aviv 14
Des Moines 13
Hyderabad 12
Philadelphia 12
Princeton 12
Vienna 12
Barcelona 11
Messina 11
Orem 11
Brussels 10
Chennai 10
Nuremberg 10
Warsaw 10
Chicago 9
Ludwigshafen am Rhein 9
Mexico City 9
Naples 9
Phoenix 9
San Diego 9
Birmingham 8
Lawrence 8
Brest 7
Brooklyn 7
Cambridge 7
Da Nang 7
Nanjing 7
Napoli 7
Osaka 7
Redwood City 7
Riyadh 7
Atlanta 6
Biên Hòa 6
Catania 6
Guangzhou 6
Hoover 6
Istanbul 6
Lappeenranta 6
Montreal 6
Mumbai 6
Rio de Janeiro 6
Sydney 6
Vittoria 6
Altamura 5
Baton Rouge 5
Belo Horizonte 5
Bexley 5
Jeddah 5
New Delhi 5
Redondo Beach 5
Shanghai 5
Stockholm 5
Tashkent 5
Toronto 5
Washington 5
Zurich 5
Athens 4
Aversa 4
Basingstoke 4
Buenos Aires 4
Charlotte 4
Totale 2.628
Salva come PNG Salva come JPEG
Nome #
A comprehensive computational analysis of NR2F2/6 receptors for drug repurposing 247
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies 246
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 231
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) 200
FTSJ1 INHIBITION AS A STRATEGY FOR NONSENSE MUTATION SUPPRESSION IN TP53: INTEGRATIVE COMPUTATIONAL AND EXPERIMENTAL ANALYSIS 196
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 196
NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS RESCUING NONSENSE MUTATED TP53: STRATEGIES AGAINST CANCER 187
Potential translational readthough inducin drugs: an optimized design and synthesis of new chemical scaffolds 176
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings 173
INVESTIGATING THE NR2F2 STRUCTURE FOR DRUG REPURPOSING 168
Investigating the inhibition of FTSJ1 a tryptophan tRNA-specific 2’-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in nonsense mutated CFTR 165
Design of small molecules and identification of putative anticancer therapeutic targets via in silico tools 159
RESCUING P53 BY NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS 157
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors 148
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 141
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies 140
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects 136
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics 131
Sulfonamide moiety as "molecular chimera" in the design of new drugs 126
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors 123
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 122
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING 121
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 114
Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation 112
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test 112
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity 111
Beyond Nonsense: New Molecules as Precision Therapy for Rare Genetic Diseases 105
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 105
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors 99
Treatment of Complex Regional Pain Syndrome (Crps): New Perspectives in the Use of Sulfonamides as Modulators of P2x Receptors 77
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 76
Unveiling Novel Hybrids Quinazoline/Phenylsulfonylfuroxan Derivatives with Potent Multi-Anticancer Inhibition: DFT and In Silico Approach Combining 2D-QSAR, Molecular Docking, Dynamics Simulations, and ADMET Properties 73
Biophysical insights into the pathogenicity of rare genetic disease-associated proteins 70
CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives 70
Non-covalent immunoproteasome inhibitors: virtual screening and in vitro test on β1i /β5i subunits 68
Design, Synthesis, Characterization, in Vitro Biological Evaluation, and in Silico Investigation of 4-Substituted Arylidene Pyrazolones Through Docking, Molecular Dynamics Simulations, and DFT Studies 61
Docking in the Dark: Insights into Protein–Protein and Protein–Ligand Blind Docking 46
QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics 28
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design 9
Totale 5.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.951
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022194 12 30 15 9 1 7 19 12 16 21 16 36
2022/2023351 30 38 9 29 63 55 22 25 28 5 20 27
2023/2024264 29 19 17 8 15 52 21 8 2 27 25 41
2024/20251.006 21 24 37 97 41 84 70 121 76 117 96 222
2025/20262.754 173 61 205 336 263 394 366 270 189 174 148 175
2026/202796 96 0 0 0 0 0 0 0 0 0 0 0
Totale 5.025